VeriMomVeriMom
HIGH RISK

Should I Avoid gemfibrozil During Pregnancy? | VeriMom

Reviewed by · Last reviewed

ECHA regulatory hazard statements

  • H360D
  • H361

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Sources & references

Authoritative references used to score this ingredient.

Pregnancy-Safe Alternatives to gemfibrozil | VeriMom

IngredientsPregnancy-Safe Ingredients Database — 28,000+ Ingredients Rated

See also

FAQ

Is gemfibrozil safe during pregnancy?
Animal reproductive and developmental toxicity (rats/rabbits) reported (dose-related decreases in conception, increased stillbirths, fetal skeletal variations and rare anophthalmia); regulatory/product literature flags suspected reproductive toxicity (H361) though no clear harmonised CLP entry was found. Mechanism is not well‑characterized for reproductive effects; likely related to pharmacologic/lipid‑metabolism effects seen with systemic exposure. Topical cosmetic exposure would give low but measurable systemic absorption in typical circumstances, so exposure is not negligible for pregnancy concerns. Sources: Drugs.com summary (drug pregnancy warnings), product monograph and animal study summaries, SDS/classification listings.
Is gemfibrozil safe while breastfeeding?
Authoritative lactation sources (LactMed / drug monographs) advise avoidance during breastfeeding because of concern for disruption of infant lipid metabolism and because gemfibrozil is systemically absorbed and may transfer to milk. Reproductive/developmental animal data support suspected hazard. Topical cosmetic use would generally give low exposure, but milk transfer risk under systemic use is established. Sources: LactMed, product monograph, Drugs.com.
Is gemfibrozil safe for baby skin?
Because animal developmental toxicity has been observed, hazard for infants is flagged as suspected (H361 in several supplier/SDS listings and regulatory summaries). For infant skin (0–3 yr) exposure, immature skin increases absorption; therefore exposure score is increased by +1 relative to adult topical exposure. There are no infant‑specific dermal studies for gemfibrozil in cosmetics, and no SCCS/CIR cosmetic safety opinion was located; concern is driven by systemic reproductive/developmental toxicity observed in animal studies and regulatory/product literature. Sources: SDSs and product monograph reporting reproductive effects, LactMed, animal study summaries.
How does VeriMom score gemfibrozil?
VeriMom scores gemfibrozil at 27/100 (high risk) based on EU CosIng status, ECHA hazard classifications, and peer-reviewed PubMed studies. Our scoring pipeline is fully transparent.
What are pregnancy-safe alternatives to gemfibrozil?
See our curated list of pregnancy-safe alternatives to gemfibrozil based on similar function and a no-known-risks safety band.

Check every label in 2 seconds

Get VeriMom free — scan any product and see the pregnancy safety score instantly.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. Safety scores are based on publicly available data and may not reflect all risks. Always consult your healthcare provider before using any product during pregnancy or breastfeeding.

Get the full experience in the VeriMom app